trial · primary record
Efgartigimod Alfa
Optic Neuritis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2028-06 |
| Primary endpoint | Recruitment Rate |
| Registry ID | NCT06453694 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:28.151Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06453694
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- EFGARTIGIMOD ALFA · approval
- Efgartigimod Alfa · compound